3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion.

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Microvascular invasion (MVI) has recently been reported to be an independent prognostic factor in patients with hepatocellular carcinoma (HCC). This study compared the outcomes of adjuvant transarterial chemoembolization (A-TACE) after hepatic resection (HR) in patients with HCC involving MVI.

          Related collections

          Author and article information

          Journal
          Am. J. Surg.
          American journal of surgery
          Elsevier BV
          1879-1883
          0002-9610
          April 2019
          : 217
          : 4
          Affiliations
          [1 ] Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 530021, China; Key Laboratory for High-Incidence Tumor Prevention and Treatment, Ministry of Education, China.
          [2 ] Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 530021, China; Key Laboratory for High-Incidence Tumor Prevention and Treatment, Ministry of Education, China; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, 530021, China.
          [3 ] Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 530021, China; Key Laboratory for High-Incidence Tumor Prevention and Treatment, Ministry of Education, China; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, 530021, China. Electronic address: xitongpingjia@163.com.
          [4 ] Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 530021, China; Key Laboratory for High-Incidence Tumor Prevention and Treatment, Ministry of Education, China; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, 530021, China. Electronic address: xiangbangde@163.com.
          Article
          S0002-9610(18)30496-3
          10.1016/j.amjsurg.2018.07.054
          30103903
          c30c6c59-0089-4539-95e0-ca52df372d9e
          History

          Hepatocellular carcinoma,Microvascular invasion,Transarterial chemoembolization,Hepatic resection,Adjuvant

          Comments

          Comment on this article